BGI Genomics Co., Ltd. (300676) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BGI Genomics Co., Ltd.

Why is BGI Genomics Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -15.95% and Operating profit at -172.73% over the last 5 years

Flat results in Mar 26

INTEREST(HY) At CNY 24.35 MM has Grown at 99.27%
DEBT-EQUITY RATIO (HY) Highest at -31.51 %
CASH AND EQV(HY) Lowest at CNY 7,142.58 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -24.65%, its profits have risen by 39.7%
At the current price, the company has a high dividend yield of 0

Below par performance in long term as well as near term

Along with generating -24.65% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is BGI Genomics Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

BGI Genomics Co., Ltd.

-24.65%

-0.12

35.04%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-15.95%

EBIT Growth (5y)

-172.73%

EBIT to Interest (avg)

3.94

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.36

Sales to Capital Employed (avg)

0.38

Tax Ratio

0.90%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

30.08%

ROE (avg)

9.50%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.73

EV to EBIT

-19.72

EV to EBITDA

-72.01

EV to Capital Employed

2.08

EV to Sales

3.09

PEG Ratio

Dividend Yield

ROCE (Latest)

-10.56%

ROE (Latest)

-6.85%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.67% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 4.94 times

PRE-TAX PROFIT(Q)

At CNY -9.47 MM has Grown at 87.14%

NET PROFIT(Q)

At CNY -12.14 MM has Grown at 79.42%

-11What is not working for the Company

INTEREST(HY)

At CNY 24.35 MM has Grown at 99.27%

DEBT-EQUITY RATIO (HY)

Highest at -31.51 %

CASH AND EQV(HY)

Lowest at CNY 7,142.58 MM

Here's what is working for BGI Genomics Co., Ltd.

Pre-Tax Profit

At CNY -9.47 MM has Grown at 87.14%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -12.14 MM has Grown at 79.42%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 4.94 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -6.67% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for BGI Genomics Co., Ltd.

Interest

At CNY 24.35 MM has Grown at 99.27%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -31.51 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at CNY 7,142.58 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents